Colgate-Palmolive (NYSE:CL – Get Free Report) is projected to announce its Q4 2025 results before the market opens on Friday, January 30th. Analysts expect the company to announce earnings of $0.92 per share and revenue of $5.1288 billion for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Friday, January 30, 2026 at 8:30 AM ET.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, October 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.89 by $0.02. The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.91 earnings per share. On average, analysts expect Colgate-Palmolive to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Colgate-Palmolive Stock Performance
Colgate-Palmolive stock opened at $85.08 on Thursday. The company has a current ratio of 0.93, a quick ratio of 0.60 and a debt-to-equity ratio of 5.90. The firm has a market cap of $68.58 billion, a P/E ratio of 23.83, a P/E/G ratio of 5.78 and a beta of 0.30. Colgate-Palmolive has a 1-year low of $74.54 and a 1-year high of $100.18. The firm has a 50-day moving average of $80.46 and a 200-day moving average of $81.39.
Colgate-Palmolive Dividend Announcement
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the stock. Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price target for the company in a research report on Tuesday, December 9th. Evercore ISI lowered their target price on shares of Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating for the company in a report on Monday, November 3rd. Jefferies Financial Group set a $85.00 price target on Colgate-Palmolive in a research report on Tuesday, December 16th. Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Finally, Piper Sandler set a $88.00 price objective on Colgate-Palmolive and gave the company an “overweight” rating in a research note on Tuesday, January 6th. Eleven analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average target price of $89.44.
Check Out Our Latest Report on CL
Institutional Investors Weigh In On Colgate-Palmolive
A number of large investors have recently made changes to their positions in CL. Kelleher Financial Advisors bought a new position in Colgate-Palmolive in the 3rd quarter worth $35,000. JPL Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter valued at about $38,000. Measured Wealth Private Client Group LLC bought a new position in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $39,000. Quarry LP increased its holdings in Colgate-Palmolive by 153.1% in the 3rd quarter. Quarry LP now owns 701 shares of the company’s stock worth $56,000 after acquiring an additional 424 shares in the last quarter. Finally, Advocacy Wealth Management LLC bought a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $204,000. 80.41% of the stock is currently owned by institutional investors.
About Colgate-Palmolive
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
